• AP
Novartis Pharmaceuticals Corp., the U.S. unit of Swiss drugmaker Novartis AG said that at least three out of four patients given an experimental multiple sclerosis treatment were free of relapses for more than two years.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: